Stay updated on Tepotinib & Gefitinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib & Gefitinib in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.4, replacing the previous v3.5.3, indicating an updated set of study documents on the page. This reflects a documentation revision rather than a change to the study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-05-18T03:48:46.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Taoyuan, Taiwan has been added as a site and Taoyuan District, Taiwan has been removed from the study locations. This updates the geographic footprint of the trial sites for INSIGHT.
    Difference
    0.0%
    Check dated 2026-05-03T15:50:51.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page’s footer “Revision” has been updated from v3.5.2 to v3.5.3, indicating a platform/version change rather than a change to the trial’s published information.
    Difference
    0.0%
    Check dated 2026-04-26T15:36:33.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    System revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:56:26.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0, replacing the prior v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T17:32:11.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T13:12:17.000Z thumbnail image

Stay in the know with updates to Tepotinib & Gefitinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.